| Announce Date | 11/03/2025 |
| EPS Normalized Actual | $-0.07 (Miss by $-0.04) |
| EPS GAAP Actual | $-0.07 (Miss by $-0.04) |
| Revenue Actual | $0.006323B |
| Revenue Surprise | Beat by $6.323M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 0 | INF | 0 | 0 | 2 |
| Dec 2028 | 0.3 | 5.3 | 0.17234 | 0.47011 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.0748 | -0.0748 | 0.006323B | 87.55% | 6.32M |
| FQ2 2025 (Jun 2025) | -0.06 | -0.06 | 0.010435B | 55.42% | 10.44M |
| FQ1 2025 (Mar 2025) | -0.03 | -0.03 | 0B | INF% | 0M |
| FQ4 2024 (Dec 2024) | 0 | 0 | 0.022653B | 75.32% | 22.65M |
| FQ3 2024 (Sep 2024) | -0.0234 | -0.0234 | 0.000787B | -13.98% | 0.79M |
| FQ2 2024 (Jun 2024) | -0.023 | -0.023 | 0.00465204B | 99.16% | 4.65M |
| FQ1 2024 (Mar 2024) | -0.0667 | -0.0667 | -0.001139B | 95% | -1.14M |
| FQ4 2023 (Dec 2023) | -0.0208 | -0.0208 | 0.00559138B | 99.66% | 5.59M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2029 (Dec 2029) | 0 | -- | 0 | 0 | 0 |
| FQ3 2029 (Sep 2029) | 0 | -- | 0 | 0 | 0 |
| FQ2 2029 (Jun 2029) | 0 | -- | 0 | 0 | 0 |
| FQ1 2029 (Mar 2029) | 0 | -- | 0 | 0 | 0 |
| FQ4 2028 (Oct 2028) | 0 | -- | 0 | 0 | 1 |
| FQ3 2028 (Jul 2028) | 0 | -- | 0 | 0 | 1 |
| FQ2 2028 (Jun 2028) | 0 | -- | 0 | 0 | 1 |
| FQ1 2028 (Mar 2028) | 0 | -- | 0 | 0 | 1 |
| FQ4 2027 (Oct 2027) | 0 | -- | 0 | 0 | 0 |
| FQ3 2027 (Jul 2027) | 0 | -- | 0 | 0 | 0 |
| FQ2 2027 (Jun 2027) | 0 | -- | 0 | 0 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2029 (Dec 2029) | 0.1B | -- | 0.1B | 0.1B | 1 |
| FQ3 2029 (Sep 2029) | 0.08B | -- | 0.08B | 0.08B | 1 |
| FQ2 2029 (Jun 2029) | 0.01B | -- | 0.01B | 0.01B | 1 |
| FQ1 2029 (Mar 2029) | 0.06B | -- | 0.06B | 0.06B | 1 |
| FQ4 2028 (Oct 2028) | 0.02B | -- | 0.02B | 0.02B | 0 |
| FQ3 2028 (Jul 2028) | 0.03B | -- | 0.03B | 0.03B | 0 |
| FQ2 2028 (Jun 2028) | 0.03B | -- | 0.03B | 0.03B | 1 |
| FQ1 2028 (Mar 2028) | 0.02B | -- | 0.02B | 0.02B | 1 |
| FQ4 2027 (Oct 2027) | 0.02B | -- | 0.02B | 0.02B | 1 |
| FQ3 2027 (Jul 2027) | 0.03B | -- | 0.03B | 0.03B | 1 |
| FQ2 2027 (Jun 2027) | 0.03B | -- | 0.03B | 0.03B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
0
EPS # of Misses
7
EPS # of in-lines
1
Revenue # of Beats
6
Revenue # of Misses
1
Revenue # of in-lines
1
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.0748 | -0.0748 | 100% | |
| FQ2 2025 (Jun 2025) | -0.06 | -0.06 | 100% | |
| FQ1 2025 (Mar 2025) | -0.03 | -0.03 | 100% | |
| FQ4 2024 (Dec 2024) | 0 | 0 | NAN% | |
| FQ3 2024 (Sep 2024) | -0.0234 | -0.0234 | 100% | |
| FQ2 2024 (Jun 2024) | -0.023 | -0.023 | 100% | |
| FQ1 2024 (Mar 2024) | -0.0667 | -0.0667 | 100% | |
| FQ4 2023 (Dec 2023) | -0.0208 | -0.0208 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $0.01B | $6.32M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $0.01B | $10.44M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0B | $0M | NAN% |
| FQ4 2024 (Dec 2024) | $0B | $0.02B | $22.65M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0B | $0.79M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0B | $4.65M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $-0B | $-1.14M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.01B | $5.59M | 100% |